VitalPoint Technologies, Inc. Appoints Dr. Jordan Balencic, D.O. of the Veterans Administration, as Strategic Healthcare Adviser

VitalPoint Technologies, Inc. Appoints Dr. Jordan Balencic, D.O. of the Veterans Administration, as Strategic Healthcare Adviser

  • Dr. Jordan Balencic, D.O., renowned for mental health and alternative medication expertise, joins VitalPointTech as Strategic Healthcare Adviser.
  • His extensive Veterans Administration experience positions VitalPointTech to innovate tailored healthcare for veterans.
  • The appointment aligns with the interest in exploring veteran-focused alternative treatments, notably psychedelics.
  • Supported by political initiatives and figures like former Texas Governor Rick Perry, VitalPointTech plans to lead in psychedelic research for veterans.
  • Dr. Balencic’s role represents a transformative moment in VitalPointTech’s mission to redefine veterans’ healthcare with expertise, connections, and a vision for veteran well-being.

Houston, Texas – October 5, 2023 – VitalPoint Technologies, Inc. (“VPT”) is delighted to announce the appointment of Dr. Jordan Balencic, a distinguished Veterans Administration D.O. and accomplished venture capitalist specializing in mental health, anti-opioid solutions, and alternative medicine applications. This strategic move marks a pivotal moment in our commitment to advancing the alternative medicine sector for veterans’ care.

Dr. Jordan Balencic, a visionary in the healthcare industry, will assume the role of Strategic Healthcare Adviser at VitalPoint Technologies. With a profound understanding of the healthcare landscape and a passion for innovation, Dr. Balencic’s appointment will drive our mission to redefine healthcare solutions for veterans.

“I am deeply honored to join the VitalPointTech team, and I am genuinely passionate about our shared vision. My extensive experience at the Veterans Administration has provided me with invaluable insights into the unique healthcare needs of our veterans. In my new role as Strategic Healthcare Adviser at VitalPointTech, I am committed to making a meaningful impact on the lives of those who have served our country. At VitalPointTech, we’re not just aiming to provide care; we’re pioneering research and leading the industry in delivering innovative psychedelic solutions to veterans. Together, we are charting a course towards a brighter future for their health and well-being.”

Psychedelics For Veterans

In recent times, there has been a growing recognition of the potential benefits of psychedelic treatments for veterans dealing with a range of mental health challenges, including PTSD, depression, and anxiety. These alternative treatments have shown promising results in clinical trials, offering new hope for veterans seeking relief from the burdens of their service-related traumas.

According to a recent article published by the Veterans Administration [source: Veterans Care], there is a significant effort underway to explore the use of psychedelics in the treatment of veterans. The article highlights ongoing research and clinical trials aimed at understanding how substances like psilocybin and MDMA may provide relief and healing to veterans suffering from mental health issues.

Dr. Balencic’s extensive background in both healthcare and venture capital uniquely positions him to contribute to these groundbreaking developments. His appointment aligns perfectly with VitalPoint Technologies’ commitment to advancing alternative medicine solutions that prioritize the well-being of our nation’s veterans.

Political Support

According to a Reuters report [source: Reuters], U.S. lawmakers, including Congressman Dan Crenshaw, have been making a bipartisan push for psychedelic research in the defense bill. This signifies a significant step towards acknowledging the therapeutic potential of psychedelics for veterans and military personnel.

Furthermore, the Texas Tribune [source: Texas Tribune] has reported on the efforts within the state of Texas to explore the use of psychedelics for veterans suffering from PTSD. This aligns with VitalPoint Technologies’ commitment to providing alternative and effective healthcare solutions for veterans.

Congressman Dan Crenshaw, known for his unwavering support for veterans, unveiled the “Douglas Mike Day Psychedelic Therapy to Save Lives Act” [source: Crenshaw.house.gov]. This legislation underscores the importance of psychedelic therapy for veterans, emphasizing its potential to save lives and improve the mental health and well-being of those who have served our nation.

“This is about studying psychedelic treatments via clinical trials in the Department of Defense,” Crenshaw said during a House Rules Committee hearing. “Psychedelic treatments to treat PTSD, to treat TBIs, it is shown to be very effective. There’s a lot of evidence that it is effective and there have been previous studies but we need to study it more.”

Additionally, notable political figures such as former Texas Governor Rick Perry and Congresswoman Alexandria Ocasio-Cortez have shown interest in and support for psychedelic research, further highlighting the bipartisan and cross-spectrum consensus on the importance of exploring these innovative therapies.

In a joint press conference with Crenshaw, Ocasio-Cortez said their goal is to “celebrate the enormous amount of progress being made in the study and advancement of psychedelic research in the application for PTSD for our veterans community, as well as many other survivors across the country.”

About Dr. Jordan Balencic

Dr. Jordan Balencic boasts a diverse and impressive career history. As the Co-Founder of Evermind since October 2019, Dr. Balencic has played a pivotal role in the company’s success. Prior to this, he founded BrainPower Capital in August 2017 and served as its CEO. In May 2011, Dr. Balencic established the Balencic Creative Group, where he held the position of Chief Executive Officer.

In the medical realm, Dr. Balencic has excelled as an Internal Medicine Physician at the U.S. Department of Veterans Affairs since August 2016. His dedication to healthcare also includes a prior role as a Resident Physician specializing in Internal Medicine at Penn State Milton S. Hershey Medical Center from July 2013 to June 2016. Dr. Balencic is affiliated with the Lebanon Veterans Affairs Medical Center in Hershey, Pennsylvania.

Beyond his medical career, Dr. Balencic has showcased leadership qualities in diverse fields. He served as a Senior Fellow at The Social Enterprise Service Group™ (SESG) from July 2016 to October 2018 and held the position of Chairman of the Board at Mitesco, Inc. from September 2016 to September 2018.

Dr. Jordan P. Balencic’s entrepreneurial spirit shines through his ventures, where he has garnered expertise in both healthcare and business sectors.

Dr. Balencic earned his Bachelor of Science (B.S.) degree in Human Biology from Gannon University between 2005 and 2009. He furthered his education at Lake Erie College of Osteopathic Medicine, where he obtained his Doctor of Osteopathic Medicine degree from 2009 to 2013. Following his medical degree, Dr. Balencic completed the Internal Medicine Residency Program at Penn State College of Medicine from 2013 to 2016.

As a physician entrepreneur, Dr. Jordan Balencic is dedicated to merging his clinical and business acumen to enhance human health. With over a decade of entrepreneurial experience in the health and wellness industry, he has made significant contributions. Dr. Balencic is the mastermind behind EVERMIND™, a science-supported, plant-based Cognitive Health Elixir set to launch in 2023. His strengths encompass product and packaging commercialization, research and development, business expansion, capital procurement, public markets, corporate governance, and board advisory. Dr. Balencic’s extensive experience spans from startups to small-cap publicly traded companies.

Dr. Balencic’s medical journey includes completing his Internal Medicine residency training at Pennsylvania State University, earning his medical doctoral degree at Lake Erie College of Osteopathic Medicine, and obtaining a bachelor’s degree in biology from Gannon University.

Robert Yrshus, Chief Executive Officer of VitalPoint Technologies, emphasized the significance of this appointment, stating, “Dr. Balencic’s appointment represents a pivotal moment for VitalPointTech and our commitment to redefining veterans’ healthcare. As we collaborate with leaders like Dr. Balencic as well as hopefully others like Governor Perry, and Congressman Crenshaw, and with the support of forward-thinking political initiatives, we are poised to revolutionize the way veterans receive care, ensuring they get the best treatments available.”

About VitalPoint Technologies, Inc.

VitalPoint Technologies, Inc. is a trailblazing healthcare organization dedicated to advancing alternative healthcare solutions through cutting-edge research, innovative product development, and comprehensive education. Our mission-driven approach focuses on addressing critical healthcare challenges, including veteran suicides, opioid addiction, and treatment-resistant mental health conditions.

Our Subsidiaries:

Herban Healing: Our subsidiary, Herban Healing, is a rapidly expanding bio-pharmaceutical company positioned at the forefront of providing non-opioid alternatives to hospice patients. We are in the process of establishing a transformative research partnership with a major university, the details of which will be announced in the near future. Once confirmed, this research has the potential to revolutionize end-of-life care and pave the way for anti-opioid and opioid withdrawal treatments, which could be instrumental in addressing the pain management and addiction epidemic, including the needs of veterans.

Bloomi Labs: Our subsidiary, Bloomi Labs, is dedicated to research and innovation, particularly in the realm of healthcare worker safety and well-being. Our specialized product research and upcoming projects have the potential to significantly enhance sanitation practices and reduce inflammation, improving the healthcare environment for all.

Our Vision:

Founded by a collective of veterans, medical professionals, and financial advocates, VitalPoint Technologies, Inc. envisions a future where healthcare is redefined with the well-being of individuals at its core. We are committed to exploring alternative healthcare options, such as CBD and psilocybin, to address the pressing healthcare challenges of our time.

Strategic Location:

Our headquarters are strategically located in Houston, Texas, providing us with proximity to the Texas Medical Center, the largest medical city globally. Additionally, we are situated in a region with the second-largest veteran population in the United States, comprising over 300,000 veterans. This location allows us to collaborate with leading medical institutions, engage with a diverse patient demographic, and make a meaningful impact on healthcare innovation.

At VitalPoint Technologies, Inc., we are dedicated to pioneering healthcare solutions, fostering groundbreaking research, and educating the healthcare community about alternative options. Our commitment to improving the lives of individuals, particularly veterans, drives us forward as we strive for a healthier and more compassionate future.

Corporate Website:                   https://VitalPointTech.com

Herban Healing:                        https://herban-healing.com

 

Contact: 

Robert Yrshus, Executive Chairman

Address:   3730 Kirby Drive # 1200

                   Houston, TX 77098

Phone:      1-512-522-0360‬

Email:       [email protected]   

Forward-Looking Statements Certain statements herein, including statements regarding the extent and timing of our production and other operations, and our liquidity, are “forward-looking statements” that are subject to risks and uncertainties. These forward-looking statements are based on management’s current expectations. Various important factors could cause actual results to differ materially, including the risks identified in our filings with the Securities and Exchange Commission. VitalPoint Technologies, Inc. disclaim any obligation to update this information. Certain statements in this press release are forward-looking and involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases.  You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.

 

Read Full Disclaimer:https://vitalpointtech.com/disclaimer/  

Scroll to Top